Literature DB >> 12799789

[Rhabdomyolysis and myoglobinuria].

A Lindner1, S Zierz.   

Abstract

Rhabdomyolysis is a disorder characterized by acute damage of the sarcolemma of the skeletal muscle leading to release of potentially toxic muscle cell components into the circulation, most notably creatine phosphokinase (CK) and myoglobin, and is frequently accompanied by myoglobinuria. Therefore, the term myoglobinuria is often used interchangeably with the term rhabdomyolysis. This disorder may result in potential life-threatening complications such as acute myoglobinuric renal failure, hyperkalemia and cardiac arrest, disseminated intravascular coagulation, and compartment syndrome. The condition is etiologically heterogeneous and may result from a large variety of diseases affecting muscle membranes, membrane ion channels, and muscle energy supply including acquired causes (e.g., exertion, crush injury and trauma, alcoholism, drugs, and toxins) and hereditary causes (e.g., disorders of carbohydrate metabolism, disorders of lipid metabolism, or diseases of the muscle associated with malignant hyperthermia). In many patients with idiopathic recurrent rhabdomyolysis, specific inherited metabolic defects have not been recognized up to now.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799789     DOI: 10.1007/s00115-003-1518-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  94 in total

Review 1.  Neuroleptic malignant syndrome.

Authors:  P Adnet; P Lestavel; R Krivosic-Horber
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

Review 2.  Myoglobinuria.

Authors:  W S David
Journal:  Neurol Clin       Date:  2000-02       Impact factor: 3.806

Review 3.  Catastrophic medical events with exhaustive exercise: "white collar rhabdomyolysis".

Authors:  J P Knochel
Journal:  Kidney Int       Date:  1990-10       Impact factor: 10.612

4.  The second wind phenomenon in McArdle's disease.

Authors:  J P Braakhekke; M I de Bruin; D F Stegeman; R A Wevers; R A Binkhorst; E M Joosten
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

5.  Rhabdomyolysis and myoglobinuria.

Authors:  J P Knochel
Journal:  Annu Rev Med       Date:  1982       Impact factor: 13.739

Review 6.  Rhabdomyolysis in childhood. A primer on normal muscle function and selected metabolic myopathies characterized by disordered energy production.

Authors:  R A Brumback; D L Feeback; R W Leech
Journal:  Pediatr Clin North Am       Date:  1992-08       Impact factor: 3.278

7.  Hypokalemic rhabdomyolysis and acute renal failure. Occurrence following total parenteral nutrition.

Authors:  S M Nadel; J W Jackson; D W Ploth
Journal:  JAMA       Date:  1979-05-25       Impact factor: 56.272

Review 8.  Recognition, assessment and management of neuroleptic malignant syndrome.

Authors:  M Khan; D Farver
Journal:  S D J Med       Date:  2000-09

9.  Alcohol-associated rhabdomyolysis: ethanol induction of cytochrome P450 may potentiate myotoxicity.

Authors:  J E Riggs
Journal:  Clin Neuropharmacol       Date:  1998 Nov-Dec       Impact factor: 1.592

10.  Rhabdomyolysis in the hyperosmolal state.

Authors:  P C Singhal; M Abramovici; J Venkatesan
Journal:  Am J Med       Date:  1990-01       Impact factor: 4.965

View more
  7 in total

1.  Asymptomatic hypothyroidism and statin-induced myopathy.

Authors:  Simona L Bar; Daniel T Holmes; Jiri Frohlich
Journal:  Can Fam Physician       Date:  2007-03       Impact factor: 3.275

2.  [Compartment syndrome caused by rhabdomyolysis in the context of pychogenic polydipsia].

Authors:  F Sauer; A Lenz; D Popp; W Strecker
Journal:  Unfallchirurg       Date:  2015-05       Impact factor: 1.000

3.  [Rhabdomyolysis under treatment with venlafaxine and risperidone].

Authors:  R Weisser; S Jalili; E Haen; W Schulte-Mattler; T C Wetter
Journal:  Nervenarzt       Date:  2020-02       Impact factor: 1.214

Review 4.  Propofol infusion syndrome: an overview of a perplexing disease.

Authors:  Vincenzo Fodale; Enza La Monaca
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  Clinical spectrum of rhabdomyolysis presented to pediatric emergency department.

Authors:  Chun-Yu Chen; Yan-Ren Lin; Lu-Lu Zhao; Wen-Chieh Yang; Yu-Jun Chang; Kang-Hsi Wu; Han-Ping Wu
Journal:  BMC Pediatr       Date:  2013-09-03       Impact factor: 2.125

Review 6.  Nephrotoxicity of methadone: a systematic review.

Authors:  Samira Alinejad; Kazem Ghaemi; Mohammad Abdollahi; Omid Mehrpour
Journal:  Springerplus       Date:  2016-12-09

Review 7.  Rhabdomyolysis: Revisited.

Authors:  Ankur Gupta; Peter Thorson; Krishnam R Penmatsa; Pritam Gupta
Journal:  Ulster Med J       Date:  2021-07-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.